Advancements in Breast Cancer Treatments

This chapter explores recent developments in breast cancer therapies, highlighting the efficacy of PI3 kinase inhibitors and antibody-drug conjugates like TDXD. It emphasizes personalized treatment strategies based on patient-specific factors and reviews key findings from clinical trials, particularly the Destiny Breast 06 study. The discussion also covers the complexities of treating HER2-positive and triple-negative breast cancer, showcasing innovative approaches and ongoing research in the field.